Chen XiaoFei, Hao LingLi, Zhou Yujing, Zhang Huihui, Wang Huaying, Yu Wanjun
Department of Respiratory and Critical Care Medicine, The Affiliated People's Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
J Inflamm Res. 2025 May 31;18:7105-7114. doi: 10.2147/JIR.S521440. eCollection 2025.
While both the systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) have demonstrated prognostic value in various diseases, the clinical utility of their combined score (SII-PNI) for predicting outcomes in patients with severe community-acquired pneumonia (SCAP) remains incompletely understood. The aim of this study is to explore the predictive value of SII-PNI score in patients with SCAP.
We conducted a retrospective analysis of the clinical data of 138 patients diagnosed with SCAP. The SII, PNI, and the SNII-PNI score were calculated. Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal threshold of SII-PNI. Multivariable logistic regression models were used to assess the association between the SII-PNI score and 28-day mortality.
The cutoff values for predicting 28-day mortality were >4689.82 for SII and <32.18 for PNI, respectively, with sensitivities of 59.1% and 60.3% and specificities of 85.3% and 68.2%. Multivariate analysis reveals that a SII-PNI score of 2 (OR, 14.11; 95% CI, 3.18-62.66; p = 0.001) was independently associated with a high risk of 28-day mortality.
Our results indicate that a higher SII-PNI score at admission was linked to poor prognosis in SCAP patients. The combined SII-PNI score can effectively help clinicians assess disease progression and optimize risk assessment and clinical management for SCAP patients.
虽然全身免疫炎症指数(SII)和预后营养指数(PNI)在多种疾病中均显示出预后价值,但它们的综合评分(SII-PNI)对预测重症社区获得性肺炎(SCAP)患者结局的临床效用仍未完全明确。本研究旨在探讨SII-PNI评分对SCAP患者的预测价值。
我们对138例诊断为SCAP的患者的临床资料进行了回顾性分析。计算了SII、PNI和SII-PNI评分。进行受试者工作特征(ROC)曲线分析以确定SII-PNI的最佳阈值。使用多变量逻辑回归模型评估SII-PNI评分与28天死亡率之间的关联。
预测28天死亡率的SII临界值>4689.82,PNI临界值<32.18,敏感性分别为59.1%和60.3%,特异性分别为85.3%和68.2%。多变量分析显示,SII-PNI评分为2(比值比,14.11;95%置信区间,3.18-62.66;p = 0.001)与28天高死亡风险独立相关。
我们的结果表明,入院时较高的SII-PNI评分与SCAP患者的不良预后相关。联合SII-PNI评分可有效帮助临床医生评估疾病进展,并优化SCAP患者的风险评估和临床管理。